XML 41 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note 3 - Collaborative and Other Research and Development Contracts (Details Textual) - USD ($)
 1 Months Ended 9 Months Ended 50 Months Ended
Jun. 16, 2015
Sep. 30, 2013
Feb. 24, 2011
May. 31, 2010
Sep. 30, 2009
Jan. 31, 2007
Jun. 30, 2006
Sep. 30, 2015
Feb. 24, 2011
Mar. 31, 2015
US Department of Health and Human Services [Member]                    
Contract Term           4 years        
Collaborative Agreement Contract Value           $ 102,661,000        
Collaborative Agreement Additional Contract Value     $ 55,000,000   $ 77,191,000          
Collaborative Agreement Adjusted Contract Value                 $ 234,852,000  
National Institute of Allergy and Infectious Diseases [Member]                    
Proceeds from awards for Research and Development Contracts   $ 5,000,000           $ 29,875    
Expected Receivable From Awards for Research and Development Contracts               $ 34,002,000    
Collaborative Agreement Period of Contract               5 years    
UAB [Member]                    
Period of Agreement               25 years    
Renewable Period of Agreement               5 years    
Base Contract [Member]                    
Government Contract Receivable                   $ 13,314,000
Additional Development Options [Member]                    
Government Contract Receivable                   22,855,000
ASPRBARDA Contract [Member]                    
Government Contract Receivable                   $ 36,169,000
Proceeds from awards for Research and Development Contracts               $ 16,300,000    
Green Cross Corporation [Member]                    
Proceeds from License Fees Received             $ 250,000      
AECOM and IRL [Member]                    
Milestone Payment Maximum               4,000,000    
Milestone Payment Minimum               1,400,000    
Annual License Fee Minimum               150,000    
Annual License Fee Maximum               $ 500,000    
Advance Notice Period for Termination of Agreement               60 days    
Stock Issued During Period, Value, for Modification of License Agreement       $ 5,911,000            
Payments for Modification of License Agreement       $ 90,000            
CSL Limited [Member                    
Proceeds from License Fees Received $ 33,740,000                  
Milestone Payment Maximum $ 12,000,000                  
Royalty Term 10 years